Search results
Destiny 2: The Final Shape campaign walkthrough
Shacknews· 14 hours agoA complete guide for The Final Shape campaign including mission list and Legendary version tips.
Hunter's Journal perks, The Final Shape Artifact - Destiny 2
Shacknews· 6 days agoAll the perks for the Hunter's Journal, the Artifact players will be utilizing in Destiny 2: The...
Ocugen (OCGN) Skyrockets 209.6% Year to Date: Heres Why
Zacks via Yahoo Finance· 8 hours agoOcugen is a biotechnology company focused on discovering, developing, and commercializing novel gene...
Call of Duty: Modern Warefare 3 and Warzone Update Patch Notes - Gameranx
Gameranx· 4 hours agoLeading up to the Call of Duty showcase taking place this weekened about Black Ops 6, COD MW3 and...
Elden Ring: Shadow Of The Erdtree Adds New Difficulty Modifiers And 10 More Bosses
GameSpot· 1 day agoNot all boss fights will be mandatory.
Aputure Light Storm 600c Pro II Nearly Doubles the Brightness, Adds IP54 Weather Rating
The Joplin Globe· 5 hours agoHigh-end performance at an affordable price, the upgrade to Aputure's industry workhorse light...
Modern Warfare 3: What are Playlist Modifiers? | Season 4 - Gameranx
Gameranx· 6 days agoCall of Duty: Modern Warfare 3 Season 4 has seen the debut of Playlist Modifiers which apply to...
Squad Busters detailed guide to "git good"
Pocket Gamer· 5 days agoSquad Busters, Supercell's first global launch in more than five years, is out now! With Squad Busters’ release it’s a given that we’re going to start...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 14 hours agoVirion Therapeutics Reports Positive First-in-human, First-in-class, Phase 1b Immunogenicity Data of VRON-0200, a Novel Checkpoint Modifier for HBV Functional Cure at EASL ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 14 hours ago...today congratulates its JV partner Virion Therapeutics, LLC, a clinical-stage biotechnology company developing novel T cell-based immunotherapies, on its late breaker presentation highlighting the first-ever human immunogenicity data from its novel checkpoint modifier immunotherapy for HBV...
